press specul anoth take-over offer potenti break-up
australian report privat equiti consortium believ
work bid hl could rival potenti second bid
jangho jangho first bid per share reject hl
board januari accord press privat equiti consortium
propos involv sell diagnost imag oper one parti
rump oper sold anoth suitor
upsid break-up scenario deriv sotp valuat
hl use ev/ebitda multipl assess valuat
individu busi break-up scenario hl imag busi
sold one parti remaind oper sold anoth
scenario estim break-up valu per share hl
impli ev/ebitda multipl hl discount
break-up could result dis-synergi imag within
break-up scenario valuat assum hl imag divis sold
ebitda due modest dis-synergi assum
revenu lost given volum direct referr hl medic
centr forecast impact imag ebitda
dis-synergi multipl would appropri imag
view increas hl break-up valuat per share
upgrad neutral under-perform fundament basi
see signific earn risk continu medic centr labour cost
headwind execut risk hl achiev strateg initi
howev short term share price like remain support
continu prospect activ rais target price
base probabl bid hl occur cse
statu quo remain dcf valuat
valuat metric
chang previou ep
under-perform neutral
price month
total return forecast perspect
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
price book
return equiti
return asset
return invest cap
net debt ebitda
capital-expenditure sale
capital-expenditure depr
price apr rate under-perform neutral target price analyst gretel janu
profit tax
profit tax
unusu item tax
chang work capit
cash non-cash item
movement cash/equival
 asx close
spot exchang rate
april australian report privat equiti consortium jangho
like place bid hl note explor potenti valu hl break-
scenario
detail press report
privat equiti consortium believ work bid hl would
see compani broken sold differ parti
understood privat equiti bid consid involv sell
diagnost imag oper one parti rump oper
sold anoth suitor
exactli privat equiti group involv propos deal buy healiu
jangho believ plan put forward second bid expect
lodg fortnight feder elect
hl diagnost imag busi account revenu
ebit hl imag divis run brand healthcar imag
servic queensland diagnost imag qdi predominantli nsw
site qld site vic site
current site total made
stand-alon specialist commun imag centr
facil privat public hospit
hl midst roll new imag platform icar aim
bring improv referr patient healthcar profession experi
figur ebit imag
hl ebit divis
figur major site stand-alon centr
hl imag locat type
chart compani data credit suiss estim
view current diagnost imag industri attract govern
commit greater fund radiolog servic feder govern budget
announc april liber govern commit
introduc index ultrasound x-ray mammographi fluoroscopi
intervent radiolog ct scan juli account
servic
add two new item breast mri previous werent fund medicar
novemb
februari govern also announc expand mri program
new mri licens licens bring total invest
labor govern budget repli commit would spend
four year reduc out-of-pocket radiolog cost cancer patient includ
make mri scan cancer patient afford tripl number
mri scanner elig perform medicare-fund mri cancer around
almost mri scanner around australia
increas medicar rebat radiolog servic reli upon cancer patient
make essenti servic bulk-bil
view govern commit increas radiolog fund creat
attract market opportun higher transact multipl
potenti dis-synergi
view divest diagnost imag busi would like result dis-
synergi given volum direct referr hl medic centr
estim scenario revenu lost could translat
hit ebitda estim
deriv sotp valuat use ev/ebitda multipl assess
valuat individu busi scenario diagnost imag
busi sold one parti remaind oper sold anoth
estim break-up valu scenario hl
figur hlssotp valuat break-up scenario
discount shl
discount shl
factor dis-synergi
assumpt sotp valuat breakdown
diagnost imag sold ebitda factor dis-synergi given
volum direct referr hl medic centr assum
revenu lost translat hit ebitda estim
dis-synergi view multipl would appropri
imag premium caj ebitda respect
ev/ebitda multipl corpor cost
multipl medic centr discount estim shl
deriv hl patholog valuat back-out valuat shl australian
patholog busi impli shl current share price appli discount
hl assumpt shl
multipl shl us patholog busi averag us peer labcorp
multipl shl european oper
multipl imag averag list australian di peer caj
multipl sonic clinic servic
multipl shl medic centr sonic clinic servic busi
shl current share price impli multipl shl australian
patholog busi multipl hl assum discount hl
figur shlsotp valuat impli au patholog multipl current
patholog europ
impli shl
averag lh/dgx
averag caj/idx
upgrad neutral
fundament basi see signific earn risk continu medic
centr labour cost headwind execut risk hl achiev strateg
initi howev short term share price like support
continu prospect activ rais target price
base probabl bid hl occur cse break-up valu
statu quo remain underli dcf valuat remain
make chang earn estim
break-up bid hl
sotp valuat imag valu
figur pe trade line averag
figur discount market
hl pe rel industri ex-financi
chart compani data bloomberg professionaltm servic
new total return forecast perspect chart help visual credit suiss consensu view compani return within
context forecast risk histor trade pattern
volatil calcul annualis standard deviat weekli total return seri past month illustr variabl
stock return word risk way think one would rather take forecast return stock volatil
stock volatil shade area show one standard deviat rang base past month volatil statist
term make number brave assumpt probabl share price end insid rang month
hi-lo maximum minimum daili close price past week often handi know price momentum especi
stock trade close high low stock trade close peak momentum stock
consensu consensu suppli thomson reuter survey sell side research analyst collect dozen data
point ep dp sale target price roe mean averag target return shade area around mean
repres rang estim lowest highest estim aid visualis number import factor rang
analyst estim credit suiss estim stock sit rel consensu share price rel consensu
mean consensu rang target
return calcul capit gain plu forecast dividend yield net next month cs tgt use credit suiss
target price credit suiss forecast forward dividend gross frank consensu mean rang use
consensu target price consensu dividend forecast month forward
compani mention price
labcorp america lh
